Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+79.5%
5Y CAGR+238.6%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+79.5%/yr
Annual compound
5Y CAGR
+238.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
445.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$661.81M+221.4%
2024$205.90M-18.2%
2023$251.64M+119.9%
2022$114.44M+928.7%
2021$11.13M+648.7%
2020$1.49M-